Jiangsu Sihuan Bioengineering Co., Ltd

SZSE:000518 Stock Report

Market Cap: CN¥2.4b

Jiangsu Sihuan Bioengineering Balance Sheet Health

Financial Health criteria checks 6/6

Jiangsu Sihuan Bioengineering has a total shareholder equity of CN¥509.6M and total debt of CN¥21.6M, which brings its debt-to-equity ratio to 4.2%. Its total assets and total liabilities are CN¥653.5M and CN¥143.9M respectively.

Key information

4.2%

Debt to equity ratio

CN¥21.57m

Debt

Interest coverage ration/a
CashCN¥16.66m
EquityCN¥509.55m
Total liabilitiesCN¥143.94m
Total assetsCN¥653.49m

Recent financial health updates

No updates

Recent updates

More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%

Apr 17
More Unpleasant Surprises Could Be In Store For Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) Shares After Tumbling 26%

Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Investors Are Less Pessimistic Than Expected

Feb 26
Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Investors Are Less Pessimistic Than Expected

Financial Position Analysis

Short Term Liabilities: 000518's short term assets (CN¥506.0M) exceed its short term liabilities (CN¥115.0M).

Long Term Liabilities: 000518's short term assets (CN¥506.0M) exceed its long term liabilities (CN¥28.9M).


Debt to Equity History and Analysis

Debt Level: 000518's net debt to equity ratio (1%) is considered satisfactory.

Reducing Debt: 000518's debt to equity ratio has reduced from 11.1% to 4.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 000518 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 000518 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 47.1% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.